Valeo Pharma announces Richard J. MacKay as Chairman

19-Jan-2010 - Canada

Steve Saviuk, President and CEO of Valeo Pharma announced the appointment of Mr. Richard J. (Dick) MacKay to the position of Chairman of Valeo Pharma.

Mr. MacKay joins Valeo Pharma following his retirement from Stiefel, where he held the positions of Vice-Chairman of the Board of Directors of Stiefel Laboratories, and President of Stiefel Canada. Richard MacKay's experience in building strategic alliances and developing business in the Canadian dermatology market will be of great benefit to Valeo Pharma.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances